Allergies, Cosmetics and Production - Clinical Research Informer

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

The Pharma Data

JUNE 18, 2021

June 8, 2021 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with consumers. “BOTOX ® Cosmetic is honoring and celebrating the dynamic people who use our products. IRVINE, Calif.

Botox

Botox Cosmetics Doctor Doctors

FDA’s Recent Update to the Digital Health Policy Navigator

FDA Law Blog

DECEMBER 21, 2022

clinical guidelines); Contextually relevant reference information about a disease or condition; Drug-drug interaction and drug-allergy contraindication notifications to avert adverse drug events; Drug formulary guidelines; Duplicate testing or prescription production prevention notification (e.g.,

Cosmetics

Cosmetics Allergies Regulation Drugs

FDA Issues Two Guidance Documents on Food Allergen Labeling Requirements

FDA Law Blog

DECEMBER 8, 2022

1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., Most notably, the draft guidance clarifies that the following food products are subject to the allergen labeling requirements: Bulk containers (e.g., lampreys); Bony fish (e.g., trout); and. Cartilaginous fish (e.g., shark, rays, and skates).

Genetic Engineering

Genetic Engineering Containment Cosmetics Protein

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Consumer health innovation – where passion and science meet

pharmaphorum

DECEMBER 9, 2021

I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more. Each has its own innovation priorities, based on strong science and consumer need and these interests currently include novel delivery forms in allergy, devices for pain treatment and chronic pain solutions.

Allergies

Allergies Life Science Development Scientist

Considerations for Mobile Health Technology Developers: Part 2

pharmaphorum

OCTOBER 4, 2022

The FDA regulates software that meets the definition of a medical device in section 201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Development

Development Regulation Cosmetics Life Science

FDA Releases Draft CPG on Major Food Allergen Labeling and Cross-Contact

FDA Law Blog

MAY 23, 2023

Part 117, and the Food Allergy Safety, Treatment, Education and Research Act (2021). the product label declares “tree nut” or “fish” but fails to declare the type of tree nut or species of fish in either the ingredient list or in a separate “Contains” statement).

Containment

Containment Contamination Manufacturing Compliance

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

The Pharma Data

FEBRUARY 5, 2021

” said Dr. Sabrina Fabi , Board Certified Dermatologist and Associate Research Director at Cosmetic Laser Surgery in San Diego. American Society for Dermatologic Surgery (ASDS) consumer survey on cosmetic dermatologic procedures 2018 available at [link]. For more information and to find a provider near you, visit [link].

Dermatology

Dermatology Cosmetics Allergies Production

It’s a Cruel Summer – Two New OPDP Untitled Letters

FDA Law Blog

AUGUST 11, 2024

Mahomes, spouse to Kansas City Chiefs quarterback, Patrick Mahomes, is the mother of 2 young children with severe food allergies. The letter states the website makes false or misleading claims and representations about the benefits and efficacy of KRAZATI, thus misbranding the product. Just some food for thought.

Drugs

Drugs Production Cosmetics Allergies

FASTER Law Adds Sesame as Major Food Allergen

FDA Law Blog

APRIL 26, 2021

On Friday April 23, President Biden signed into law the Food Allergy Safety, Treatment, Education and Research (FASTER) Act that designates sesame as the ninth major food allergen. By Karin F.R. Moore & Riëtte van Laack —. This Law has been a long time coming.

Allergies

Allergies Cosmetics Containment Regulation

Juno Pharmaceuticals buys Omega Laboratories

Pharmaceutical Technology

MAY 16, 2023

It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

Cosmetics

Cosmetics Allergies Manufacturing Production

FDA Takes New Steps Regarding Evaluating Public Health Importance of Additional Food Allergens

The Pharma Data

APRIL 18, 2022

Food allergies and other types of food hypersensitivities affect millions of people in the U.S. The draft guidance focuses on immunoglobulin E antibody (IgE)-mediated food allergies, which are capable of triggering anaphylaxis and are considered the most severe and immediately life-threatening food allergies. effective Jan.

Allergies

Allergies Cosmetics Production Drugs

FASTER Law Adds Sesame as Major Food Allergen

FDA Law Blog

APRIL 26, 2021

Moore & Riëtte van Laack — On Friday April 23, President Biden signed into law the Food Allergy Safety, Treatment, Education and Research (FASTER) Act that designates sesame as the ninth major food allergen. By Karin F.R. This Law has been a long time coming.

Allergies

Allergies Cosmetics Containment Regulation

FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses

The Pharma Data

DECEMBER 13, 2020

. “Today’s first ever approval of an animal biotechnology product for both food and as a potential source for biomedical use represents a tremendous milestone for scientific innovation,” said FDA Commissioner Stephen M. Hahn , M.D. Solomon , D.V.M., director of the FDA’s Center for Veterinary Medicine. In the U.S.,

FDA Approval

FDA Approval Genome Genomics Production

FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply

The Pharma Data

MAY 27, 2022

Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with certain allergies or critical health conditions. This type of specialized medical infant formula is currently in short supply in the U.S. “We

Production

Production Manufacturing Pharmacy Cosmetics

FDA Efforts to Result in Millions of Additional Bottles of Infant Formula to Further Increase U.S. Supply

The Pharma Data

MAY 27, 2022

Some of this product is currently in stock for transport and additional product is being produced in the coming weeks and months. Department of Health and Human Services is evaluating options for getting the products to the U.S. The company has information about the products and where to find product once in the U.S.

Production

Production Manufacturing Cosmetics Allergies

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities.

Sales

Sales Manufacturing FDA Approval Life Science

To Be or Coco-Not To Be: That’s One Question Answered in FDA’s Final Guidance Documents on Food Allergens

FDA Law Blog

JANUARY 13, 2025

Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act This final guidance replaces previous draft and final guidance documents on food allergen labeling that FDA issued in November 2022, which we discussed in a previous post. 1, 2023, sesame.

Cosmetics

Cosmetics Allergies Production Containment

Clinical Research Informer

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

FDA’s Recent Update to the Digital Health Policy Navigator

Webinars

Trending Sources

FDA Issues Two Guidance Documents on Food Allergen Labeling Requirements

Webinars

Consumer health innovation – where passion and science meet

Considerations for Mobile Health Technology Developers: Part 2

FDA Releases Draft CPG on Major Food Allergen Labeling and Cross-Contact

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

It’s a Cruel Summer – Two New OPDP Untitled Letters

FASTER Law Adds Sesame as Major Food Allergen

Juno Pharmaceuticals buys Omega Laboratories

FDA Takes New Steps Regarding Evaluating Public Health Importance of Additional Food Allergens

FASTER Law Adds Sesame as Major Food Allergen

FDA Approves First-of-its-Kind Intentional Genomic Alteration in Line of Domestic Pigs for Both Human Food, Potential Therapeutic Uses

FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply

FDA Efforts to Result in Millions of Additional Bottles of Infant Formula to Further Increase U.S. Supply

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

To Be or Coco-Not To Be: That’s One Question Answered in FDA’s Final Guidance Documents on Food Allergens

Stay Connected